Transdermal Drug Delivery System - Global Market Outlook (2016-2022)

October 2016 | 137 pages | ID: T4E55748579EN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Transdermal Drug Delivery System market is accounted for $16.32 billion in 2015 and is expected to reach $36.58 billion by 2022 growing at a CAGR of 12.2%. Rising aged population, rising occurrence of chronic diseases such as diabetes and cancer and high demand for drugs for diseases requiring long-term treatment, such as diabetes are some of the factors fueling the market. Technological advancements such as inclusion of microneedles in transdermal patches, provide opportunity to the market growth.

Mechanical Array segment accounted for the largest share in the market during the forecast period owing to availability of different forms of microneedle transdermal systems. North America accounted for the largest share in the market. The growth is attributed to high number of product launches and R&D investments.

Some of the key players in Transdermal Drug Delivery Systems market include Transdermal Technologies, Inc., Echo Therapeutics, Inc., Johnson & Johnson, 3M Company, Watson Pharmaceuticals, Inc, Novartis AG, Boehringer Ingelheim GmbH, Mylan Pharmaceuticals, Inc, 4P Therapeutics, LLC, Skyepharma PLC, Noven Pharmaceuticals, Inc and Biogel Technology, Inc.

Technologies Covered:

• Microporation
• Electroporation
• Active
• Electric current
• Ultrasound
• Radio Frequency
• Mechanical arrays
• Lontophoresis
• Thermal
• Smart Pill Technology (SPT)
• Microfluidics
• Passive

Applications Covered:

• Cardiovascular
• CNS
• Hormone
• Pain Management
• Other Applications

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• Italy
• UK
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Brazil
• Argentina
• South Africa
• Egypt

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 Emerging Markets

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY TECHNOLOGY

5.1 Introduction
5.2 Microporation
5.3 Electroporation
5.4 Active
5.5 Electric current
5.6 Ultrasound
5.7 Radio Frequency
5.8 Mechanical arrays
5.9 Lontophoresis
5.10 Thermal
5.11 Smart Pill Technology (SPT)
5.12 Microfluidics
5.13 Passive

6 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY APPLICATION

6.1 Introduction
6.2 Cardiovascular
6.3 CNS
6.4 Hormone
6.5 Pain Management
6.6 Other Applications

7 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, BY GEOGRAPHY

7.1 North America
  7.1.1 US
  7.1.2 Canada
  7.1.3 Mexico
7.2 Europe
  7.2.1 Germany
  7.2.2 France
  7.2.3 Italy
  7.2.4 UK
  7.2.5 Spain
  7.2.6 Rest of Europe
7.3 Asia Pacific
  7.3.1 Japan
  7.3.2 China
  7.3.3 India
  7.3.4 Australia
  7.3.5 New Zealand
  7.3.6 Rest of Asia Pacific
7.4 Rest of the World
  7.4.1 Middle East
  7.4.2 Brazil
  7.4.3 Argentina
  7.4.4 South Africa
  7.4.5 Egypt

8 KEY DEVELOPMENTS

8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 COMPANY PROFILING

9.1 Transdermal Technologies, Inc.
9.2 Echo Therapeutics, Inc
9.3 Johnson & Johnson
9.4 3M Company
9.5 Watson Pharmaceuticals, Inc
9.6 Novartis AG
9.7 Boehringer Ingelheim GmbH
9.8 Mylan Pharmaceuticals, Inc
9.9 4P Therapeutics, LLC
9.10 Skyepharma PLC
9.11 Noven Pharmaceuticals, Inc
9.12 Biogel Technology, Inc.

List Of Tables

LIST OF TABLES

Table 1 Global Transdermal Drug Delivery Systems Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Transdermal Drug Delivery Systems Market Outlook, By Technology (2013-2022) ($MN)
Table 3 Global Transdermal Drug Delivery Systems Market Outlook, By Microporation (2013-2022) ($MN)
Table 4 Global Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2013-2022) ($MN)
Table 5 Global Transdermal Drug Delivery Systems Market Outlook, By Active (2013-2022) ($MN)
Table 6 Global Transdermal Drug Delivery Systems Market Outlook, By Electric current (2013-2022) ($MN)
Table 7 Global Transdermal Drug Delivery Systems Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 8 Global Transdermal Drug Delivery Systems Market Outlook, By Radio Frequency (2013-2022) ($MN)
Table 9 Global Transdermal Drug Delivery Systems Market Outlook, By Mechanical arrays (2013-2022) ($MN)
Table 10 Global Transdermal Drug Delivery Systems Market Outlook, By Lontophoresis (2013-2022) ($MN)
Table 11 Global Transdermal Drug Delivery Systems Market Outlook, By Thermal (2013-2022) ($MN)
Table 12 Global Transdermal Drug Delivery Systems Market Outlook, By Smart Pill Technology (SPT) (2013-2022) ($MN)
Table 13 Global Transdermal Drug Delivery Systems Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 14 Global Transdermal Drug Delivery Systems Market Outlook, By Passive (2013-2022) ($MN)
Table 15 Global Transdermal Drug Delivery Systems Market Outlook, By Application (2013-2022) ($MN)
Table 16 Global Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular (2013-2022) ($MN)
Table 17 Global Transdermal Drug Delivery Systems Market Outlook, By CNS (2013-2022) ($MN)
Table 18 Global Transdermal Drug Delivery Systems Market Outlook, By Hormone (2013-2022) ($MN)
Table 19 Global Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2013-2022) ($MN)
Table 20 Global Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2013-2022) ($MN)
Table 21 North America Transdermal Drug Delivery Systems Market Outlook, By Country (2013-2022) ($MN)
Table 22 North America Transdermal Drug Delivery Systems Market Outlook, By Technology (2013-2022) ($MN)
Table 23 North America Transdermal Drug Delivery Systems Market Outlook, By Microporation (2013-2022) ($MN)
Table 24 North America Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2013-2022) ($MN)
Table 25 North America Transdermal Drug Delivery Systems Market Outlook, By Active (2013-2022) ($MN)
Table 26 North America Transdermal Drug Delivery Systems Market Outlook, By Electric current (2013-2022) ($MN)
Table 27 North America Transdermal Drug Delivery Systems Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 28 North America Transdermal Drug Delivery Systems Market Outlook, By Radio Frequency (2013-2022) ($MN)
Table 29 North America Transdermal Drug Delivery Systems Market Outlook, By Mechanical arrays (2013-2022) ($MN)
Table 30 North America Transdermal Drug Delivery Systems Market Outlook, By Lontophoresis (2013-2022) ($MN)
Table 31 North America Transdermal Drug Delivery Systems Market Outlook, By Thermal (2013-2022) ($MN)
Table 32 North America Transdermal Drug Delivery Systems Market Outlook, By Smart Pill Technology (SPT) (2013-2022) ($MN)
Table 33 North America Transdermal Drug Delivery Systems Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 34 North America Transdermal Drug Delivery Systems Market Outlook, By Passive (2013-2022) ($MN)
Table 35 North America Transdermal Drug Delivery Systems Market Outlook, By Application (2013-2022) ($MN)
Table 36 North America Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular (2013-2022) ($MN)
Table 37 North America Transdermal Drug Delivery Systems Market Outlook, By CNS (2013-2022) ($MN)
Table 38 North America Transdermal Drug Delivery Systems Market Outlook, By Hormone (2013-2022) ($MN)
Table 39 North America Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2013-2022) ($MN)
Table 40 North America Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2013-2022) ($MN)
Table 41 Europe Transdermal Drug Delivery Systems Market Outlook, By Country (2013-2022) ($MN)
Table 42 Europe Transdermal Drug Delivery Systems Market Outlook, By Technology (2013-2022) ($MN)
Table 43 Europe Transdermal Drug Delivery Systems Market Outlook, By Microporation (2013-2022) ($MN)
Table 44 Europe Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2013-2022) ($MN)
Table 45 Europe Transdermal Drug Delivery Systems Market Outlook, By Active (2013-2022) ($MN)
Table 46 Europe Transdermal Drug Delivery Systems Market Outlook, By Electric current (2013-2022) ($MN)
Table 47 Europe Transdermal Drug Delivery Systems Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 48 Europe Transdermal Drug Delivery Systems Market Outlook, By Radio Frequency (2013-2022) ($MN)
Table 49 Europe Transdermal Drug Delivery Systems Market Outlook, By Mechanical arrays (2013-2022) ($MN)
Table 50 Europe Transdermal Drug Delivery Systems Market Outlook, By Lontophoresis (2013-2022) ($MN)
Table 51 Europe Transdermal Drug Delivery Systems Market Outlook, By Thermal (2013-2022) ($MN)
Table 52 Europe Transdermal Drug Delivery Systems Market Outlook, By Smart Pill Technology (SPT) (2013-2022) ($MN)
Table 53 Europe Transdermal Drug Delivery Systems Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 54 Europe Transdermal Drug Delivery Systems Market Outlook, By Passive (2013-2022) ($MN)
Table 55 Europe Transdermal Drug Delivery Systems Market Outlook, By Application (2013-2022) ($MN)
Table 56 Europe Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular (2013-2022) ($MN)
Table 57 Europe Transdermal Drug Delivery Systems Market Outlook, By CNS (2013-2022) ($MN)
Table 58 Europe Transdermal Drug Delivery Systems Market Outlook, By Hormone (2013-2022) ($MN)
Table 59 Europe Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2013-2022) ($MN)
Table 60 Europe Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2013-2022) ($MN)
Table 61 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Country (2013-2022) ($MN)
Table 62 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Technology (2013-2022) ($MN)
Table 63 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Microporation (2013-2022) ($MN)
Table 64 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2013-2022) ($MN)
Table 65 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Active (2013-2022) ($MN)
Table 66 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Electric current (2013-2022) ($MN)
Table 67 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 68 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Radio Frequency (2013-2022) ($MN)
Table 69 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Mechanical arrays (2013-2022) ($MN)
Table 70 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Lontophoresis (2013-2022) ($MN)
Table 71 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Thermal (2013-2022) ($MN)
Table 72 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Smart Pill Technology (SPT) (2013-2022) ($MN)
Table 73 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 74 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Passive (2013-2022) ($MN)
Table 75 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Application (2013-2022) ($MN)
Table 76 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular (2013-2022) ($MN)
Table 77 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By CNS (2013-2022) ($MN)
Table 78 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Hormone (2013-2022) ($MN)
Table 79 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2013-2022) ($MN)
Table 80 Asia Pacific Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2013-2022) ($MN)
Table 81 RoW Transdermal Drug Delivery Systems Market Outlook, By Country (2013-2022) ($MN)
Table 82 RoW Transdermal Drug Delivery Systems Market Outlook, By Technology (2013-2022) ($MN)
Table 83 RoW Transdermal Drug Delivery Systems Market Outlook, By Microporation (2013-2022) ($MN)
Table 84 RoW Transdermal Drug Delivery Systems Market Outlook, By Electroporation (2013-2022) ($MN)
Table 85 RoW Transdermal Drug Delivery Systems Market Outlook, By Active (2013-2022) ($MN)
Table 86 RoW Transdermal Drug Delivery Systems Market Outlook, By Electric current (2013-2022) ($MN)
Table 87 RoW Transdermal Drug Delivery Systems Market Outlook, By Ultrasound (2013-2022) ($MN)
Table 88 RoW Transdermal Drug Delivery Systems Market Outlook, By Radio Frequency (2013-2022) ($MN)
Table 89 RoW Transdermal Drug Delivery Systems Market Outlook, By Mechanical arrays (2013-2022) ($MN)
Table 90 RoW Transdermal Drug Delivery Systems Market Outlook, By Lontophoresis (2013-2022) ($MN)
Table 91 RoW Transdermal Drug Delivery Systems Market Outlook, By Thermal (2013-2022) ($MN)
Table 92 RoW Transdermal Drug Delivery Systems Market Outlook, By Smart Pill Technology (SPT) (2013-2022) ($MN)
Table 93 RoW Transdermal Drug Delivery Systems Market Outlook, By Microfluidics (2013-2022) ($MN)
Table 94 RoW Transdermal Drug Delivery Systems Market Outlook, By Passive (2013-2022) ($MN)
Table 95 RoW Transdermal Drug Delivery Systems Market Outlook, By Application (2013-2022) ($MN)
Table 96 RoW Transdermal Drug Delivery Systems Market Outlook, By Cardiovascular (2013-2022) ($MN)
Table 97 RoW Transdermal Drug Delivery Systems Market Outlook, By CNS (2013-2022) ($MN)
Table 98 RoW Transdermal Drug Delivery Systems Market Outlook, By Hormone (2013-2022) ($MN)
Table 99 RoW Transdermal Drug Delivery Systems Market Outlook, By Pain Management (2013-2022) ($MN)
Table 100 RoW Transdermal Drug Delivery Systems Market Outlook, By Other Applications (2013-2022) ($MN)